85 results
8-K
EX-99.1
ACUR
Acura Pharmaceuticals, Inc
7 Jun 21
Acura Pharmaceuticals Provides Development Update on LTX-03
10:00am
to the Investigation New Drug application on file with the Food and Drug Administration (FDA).
We, along with our Partner, Abuse Deterrent Pharmaceuticals, LLC
8-K
EX-99.1
w4nuw3tu655
12 Apr 16
Acura Pharmaceuticals Announces FDA Fast Track Designation for the Development of LTX-04
12:00am
8-K
6o6dv19iea6la1 vm1
12 Apr 16
Acura Pharmaceuticals Announces FDA Fast Track Designation for the Development of LTX-04
12:00am
424B5
08ca755iy4t
18 Apr 13
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
lu3f5y
18 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
kj6ql
20 Dec 12
Other Events
12:00am